“Ukraine’s President Zelensky to Attend G7 Summit in Japan Amidst Russo-Ukrainian War Tensions”

Outside media reports “Zelenski” prepares to go to Japan. Attended the G7 Leaders’ Meeting, the first visit to Asia since the Russo-Ukrainian War.

CNN reported, citing a source, that Ukrainian President Volodymyr Zelensky will personally travel to Japan to attend the G7 Summit.

by war ukraine was on the top agenda of this meeting. G7 leaders are expected to speak out in support of Ukraine and unveil new measures to contain Russia. in financing the war

Analysts expect G7 to discuss security in Europe and Indo-Pacific

Japan steps up security as G7 host

And for the first time Selensky has traveled to Asia since Moscow launched a full-scale attack on Ukraine in February 2022.

However, last Thursday Japan’s foreign ministry said Zelensky would attend the meeting on Sunday. After being invited by Japanese Prime Minister Fumio Kishida earlier this year.

For the G7 summit held in Hiroshima on May 19-21 amid strict security. The G7 member countries are Canada, France, Germany, Italy, Japan, and the United Kingdom. and the United States

Image: AFP

#Zelensky #prepares #visit #Japan #Join #Leaders #Meeting
2023-05-19 05:46:00

Read more:  Syria: two civilians killed in Israeli airstrike

Related News

Give a title to rank high in google for this content

The pharmaceutical company announced that its vaccine was 85% effective in preventing severe cases of RSV in older adults.

Today respiratory diseases have experienced an increase in cases in both children and adults and the respiratory syncytial virus (VRS) is one of the most common. This disease can have mild or severe symptoms, depending on each patient. The United States Food and Drug Administration (FDA) has taken a big step by approving this Wednesday the use of the Pfizer vaccine to treat RSV in older adults.

It is the second RSV vaccine the FDA has approved this month. The pharmaceutical GlaxoSmithKline It also got the green light from the regulator to market its own serum to treat the disease in older adults, The Hill reports.

RSV usually causes mild symptoms in healthy children and adults, but for the elderly it can lead to complications.

Between 60,000 and 160,000 people over the age of 65 are hospitalized each year for the disease in USA. Between 6,000 and 13,000 end up dying, according to The Hill.

In August, Pfizer announced that its vaccine was 85% effective in preventing severe cases of RSV in older adults.

In addition to the vaccine for the elderly, called Abrysvothe FDA is also considering approving Pfizer’s serum for pregnant women, which seeks to prevent RSV cases in babies.

According to the criteria of The Trust Project

Know more

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick